The Current Status and Potential of Renal Transplantation Renal failure accounts for approximately 7,000 deaths per -annum in England and Wales and about half these patients are between the ages of 5 and 55. The need for treatment in these cases is obvious and in view of the fact that the damaged renal parenchyma is beyond repair artificial dialysis or renal transplantation would appear to be the only reasonable alternative forms of treatment that we can at present envisage.
The results of renal transplants performed throughout the world by different groups were pooled and assessed up to March 1965 and are shown in Table 1 (Barnes 1965) . These data are an amalgamation of all results and obviously those centres with the greatest experience have a higher percentage of successes. Nevertheless, even with these pooled data it is obvious that considerable benefit has been obtained by patients with renal transplants. The late mortality of identical twins occurred in cases originally suffering from glomerulonephritis, who developed the same disease in the transplants. The incidence of glomerulonephritis affecting transplants appears to be higher in twins than in other cases of renal transplantation, although the reason for this is not clear. It might be that isologous tissue from the donor twin is more susceptible to the same disease than a transplant from an unrelated person. Alternatively, identical twins are not routinely treated with immunosuppressive agents which might have some inhibitory effect on the development of glomerulonephritis in non-twin transplants. In transplants between blood relatives other than identical twins, there is approximately 50 % success at a year and the superiority of sibling donors as opposed to other relatives, who are usually parents, is shown in the third column where only one kidney from a sibling deteriorated more than a year after transplantation as opposed to 14 from other blood relatives. The transplants from unrelated donors fared considerably worse. The results from unrelated live volunteer donors were only a little better than from cadaver donors. The longest survivals in each of these groups are approximately eight years for identical twins, six years for siblings excluding identical twins, five years for other blood relatives and between two and three years for unrelated donors.
The ultimate fate of renal transplants cannot be foretold but in many transplants there is a slow falling off of function as time passes, although Starzl et al. (1965) report two transplants which were biopsied after a year and were completely normal microscopically; many transplants have normal function beyond a year with only minimal histological damage. In the centres with the best results, namely Richmond, Virginia (Hume et al. 1964) , Denver (Starzl et al. 1965) and Cleveland, Ohio (Dunea et al. 1965) , between 70 % and 80 % of transplants from close relatives function more than a year as opposed to 50% of kidneys from cadavers. The factors that govern the fate of transplanted tissue are genetically determined. From experimental inbred mice it is known that the histocompatibility factors are inherited as mendelian dominant genes similar to blood group substances; in fact in murine species they are closely linked to blood group loci. However, they appear to be quite independent of blood groups in man and the dog. It is possible that there may be a connexion between some transplant factors and the P blood group in man. A recipient of a transplant will destroy the graft if there are any additional histocompatibility factors in the donated tissue that are absent from the make-up of the recipient. If a method of tissue typing, analogous to blood grouping, were developed then it would be possible to eliminate bad donor/recipient combinations. There is some evidence that there may be only a few strong histocompatibility factors relevant to clinical transplantation (Simonsen 1965) . Thus results would be expected to be poor if the donor possessed one of these factors which is absent from the recipient no matter how much immunosuppressive therapy was given. Much current research is being devoted to tissue typing and some success appears to have been achieved. However, the methods are tedious and it is difficult to obtain consistent results. The techniques involve several different approaches, namely: (1) Typing of the leucocyte agglutinins with immune sera (Dausset 1961) .
(2) Comparison of the cytotoxic effects of test immune sera against lymphoid cells of donor and recipient (Terasaki & McClelland 1964) . (3) Observation of the behaviour of mixed populations of cultured lymphocytes from donor and recipient (Bain et al. 1964 , Hirschhorn et al. 1963 ). (4) The injection of recipient lymphocytes into potential donors producing local graft-versus-host reaction which is related to the degree of histocompatibility differences between donor and recipient (Brent & Medawar 1963 ). (5) Immunization of an indifferent individual by a prior skin graft from the recipient, followed by skin grafts from potential donors. Rapid rejection of a donor skin graft would suggest sharing of tissue transplantation factors between that donor and the recipient (Matsukura et al. 1963) .
Immunosuppression is at present quite unsatisfactory. Thiopurines and steroids are only partly effective and the side-effects of both groups of drugs have been lethal. However, when the donor and recipient are not too dissimilar as far as histocompatibility factors are concerned, these agents appear to be able to prevent rejection. When the matching of the donor and recipient is poor large doses of drugs may not prevent rejection, and even if matching is good the patient may succumb to intercurrent infection no matter how much trouble is taken to maintain a sterile environment. Thus, if normal pathogens causing cross-infection are eliminated, the patient is liable to die from organisms in his gastrointestinal tract. If these are eliminated, then viruses, fungi and protozoa which are normally not pathogenic may be able to produce bizarre lethal infections. For many years workers have been looking for specific immunosuppressive agents which are nontoxic. It is likely that better agents will be found, but a complete solution to the problem of homografting may not be possible. Rejection of transplanted tissue is a fundamental biological attribute, presumably the result of millions of years of darwinian selection. To be able to cast it aside in a specific fashion without harming the organism may be beyond therapeutic endeavour. Nevertheless, renal transplantation is well worth while and a patient moribund from chronic renal disease has a reasonable chance of being restored to a satisfactory existence, even if it is only for a matter of a few years. If the transplant eventually fails it is possible to transplant another kidney. This has been done on numerous occasions and many of the second transplants are functioning well.
I feel most strongly that one of the most unfortunate controversies that has arisen in the treatment of patients with chronic renal disease has been antagonism between groups performing intermittent dialysis and those undertaking renal transplantation. Fortunately the best centres for renal transplantation quickly realized that highly efficient intermittent dialysis was essential in order to get moribund patients fit for operation and if necessary maintain them should the transplant fail. I am sure that collaboration between these two experimental methods of treating chronic renal failure is likely to produce most valuable advances in both techniques.
